TCT-1 Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

Sorin J. Brener,Patrick W. Serruys,Martin B. Leon,Marie-Claude Morice,David E. Kandzari,Roxana Mehran,A. Pieter Kappetein,Joseph F. Sabik,Yangbo Liu,Ovidiu Dressler,Ori Ben-Yehuda,Gregg W. Stone

Journal of the American College of Cardiology（2018）

引用 0|浏览24

暂无评分

摘要

The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in pts with left main coronary artery disease (LMCAD) is uncertain, an important issue given the catastrophic consequences of stent thrombosis in this location.In the EXCEL trial, 1905 pts with

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要